Trials / Completed
CompletedNCT01009658
MSG and Gastrointestinal Motility
Effect of Monosodium Glutamate on Upper Gastrointestinal Tract Motility
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 40 (estimated)
- Sponsor
- Gunma University · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this study is to clarify the physiological function of sodium glutamate by measuring its effect on upper GI motility ( gastric emptying).
Detailed description
Amino acids such as monosodium glutamate are known to stimulate both endocrine and exocrine secretion. In addition, there is a report that oral intake of glutamate evokes the activation of vagal afferent nerves in the rat. Thus, such amino acids are thought to be influential in the process of digestion and absorption. . To investigate the effect of monosodium glutamate on gastrointestinal motility, we planned a single-blind randomized study. The participants will take either monosodium glutamate or sodium chloride before the first examination of upper GI motility and the other agent before the second examination. The order of intake will be randomized by the envelope method.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | Monosodium glutamate | Oral intake of 2.0 g of monosodium glutamate on the examination day and 0.6 g of sodium chloride on the other examination day. |
| DIETARY_SUPPLEMENT | Sodium chloride | Oral intake of 0.6 g of sodium chloride on the examination day and 2.0 g of monosodium glutamate on the other examination day. |
Timeline
- Start date
- 2009-12-01
- Primary completion
- 2015-03-01
- First posted
- 2009-11-09
- Last updated
- 2015-03-26
Locations
1 site across 1 country: Japan
Source: ClinicalTrials.gov record NCT01009658. Inclusion in this directory is not an endorsement.